ACTIVE SUBSTANCE / INN

BUPROPION HYDROCHLORIDE

Brand name(s): BUPROPION HYDROCHLORIDE, ZYBAN, WELLBUTRIN, AUVELITY, CONTRAVE, NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE, WELLBUTRIN SR, FORFIVO XL
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA022497
NDA200063
ACTIVE SUBSTANCE
Bupropion Hydrochloride
REGULATORS
FDA
SPONSORS / MAH
NALPROPION, WATSON LABS INC, GLAXOSMITHKLINE
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BUPROPION HYDROCHLORIDEANDA077285WATSON LABS INCPrescription
BUPROPION HYDROCHLORIDEANDA077455WATSON LABS INCDiscontinued
FORFIVO XLNDA022497TWI PHARMSPrescription
WELLBUTRINNDA018644GLAXOSMITHKLINEDiscontinued
WELLBUTRIN SRNDA020358GLAXOSMITHKLINEPrescription
WELLBUTRIN SRNDA020358GLAXOSMITHKLINEDiscontinued
CONTRAVENDA200063NALPROPIONPrescription
NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDEANDA208043ACTAVIS LABS FL INCNone (Tentative Approval)
AUVELITYNDA215430AXSOMEPrescription
ZYBANNDA020711GLAXOSMITHKLINEDiscontinued

FULL INTELLIGENCE ON BUPROPION HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →